Literature DB >> 20354748

Behcet's disease: from East to West.

Fereydoun Davatchi1, Farhad Shahram, Cheyda Chams-Davatchi, Hormoz Shams, Abdolhadi Nadji, Massoomeh Akhlaghi, Tahereh Faezi, Zahra Ghodsi, Alireza Faridar, Farima Ashofteh, Bahar Sadeghi Abdollahi.   

Abstract

Behcet's disease (BD) is classified among vasculitides. There are actually five nationwide surveys of BD: Iran, Japan, China, Korea, and Germany. Among case series, four are on more than 200 cases (Turkey, Morocco, Tunisia, and UK). BD was classically seen around the Silk Route. Now, it is seen everywhere. The male to female ratios were, respectively (in nationwide surveys), 1.19, 0.98, 1.34, 0.63, and 1.40 to 1. The mean age at onset was 26.2, 35.7, 33.8, 29, and 26 years. Major manifestations were seen, respectively, in nationwide surveys: mucous membrane (oral aphthosis in 97%, 98%, 98%, 99%, and 98%; genital aphthosis in 65%, 73%, 76%, 83%, and 64%); skin manifestations (pseudo-folliculitis in 57%, N/A, 31%, N/A, and 62%; erythema nodosum in 22%, N/A, 38%, N/A, and 42%; ocular manifestations in 55%, 69%, 35%, 51%, and 53%). Minor manifestations were seen, respectively, in nationwide surveys: joint manifestations in 33%, 57%, 30%, 38%, and 53%; neurological manifestations in 9%, 11%, 6.5%, 4.6%, and 11%; gastrointestinal manifestations in 7%, 15.5%, 9%, 7.3%, and 12%; vascular involvement in 8.9%, 8.9%, 7.7%, 1.8%, and 13%; pulmonary manifestations in 0.3%, N/A, 2.2%, N/A, and 3.6%; cardiac manifestations in 0.5%, N/A, 4%, N/A, and 3.2%. Laboratory tests are not useful except the pathergy test, which was positive in 54%, 44%, N/A, 40%, and 34% of cases. ESR was normal in many patients. Diagnosis is based upon clinical manifestations. The International Criteria for Behcet's Disease (ICBD, 2006) may be of help, having a sensitivity of 98.2% and a specificity of 95.6% in Iranian patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20354748     DOI: 10.1007/s10067-010-1430-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  25 in total

1.  Localization of the pathogenic gene of Behçet's disease by microsatellite analysis of three different populations.

Authors:  N Mizuki; M Ota; K Yabuki; Y Katsuyama; H Ando; G D Palimeris; E Kaklamani; M Accorinti; P Pivetti-Pezzi; S Ohno; H Inoko
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-11       Impact factor: 4.799

2.  [Epidemiology and clinical manifestations of Adamantiades-Behçet disease in Germany -- current pathogenetic concepts and therapeutic possibilities].

Authors:  Andreas Altenburg; Nestor Papoutsis; Helmut Orawa; Peter Martus; Lothar Krause; Christos C Zouboulis
Journal:  J Dtsch Dermatol Ges       Date:  2006-01       Impact factor: 5.584

3.  Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group.

Authors:  G Akman-Demir; P Serdaroglu; B Tasçi
Journal:  Brain       Date:  1999-11       Impact factor: 13.501

4.  [Behçet's disease in Tunisia. Clinical study of 519 cases].

Authors:  S B'chir Hamzaoui; A Harmel; K Bouslama; M Abdallah; M Ennafaa; S M'rad; M Ben Dridi
Journal:  Rev Med Interne       Date:  2006-08-18       Impact factor: 0.728

5.  Cardiac involvement in Behçet's disease.

Authors:  S Morelli; C Perrone; L Ferrante; A Sgreccia; R Priori; P Voci; M Accorinti; P Pivetti-Pezzi; G Valesini
Journal:  Cardiology       Date:  1997 Nov-Dec       Impact factor: 1.869

6.  Behçet's disease in Saudi Arabia.

Authors:  A N al-Dalaan; S R al Balaa; K el Ramahi; Z al-Kawi; S Bohlega; S Bahabri; M A al Janadi
Journal:  J Rheumatol       Date:  1994-04       Impact factor: 4.666

7.  Human leukocyte antigen serologic and DNA typing of Behçet's disease and its primary association with B51.

Authors:  N Mizuki; H Inoko; N Mizuki; H Tanaka; J Kera; K Tsuiji; S Ohno
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-11       Impact factor: 4.799

Review 8.  HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies.

Authors:  Mathilde de Menthon; Michael P Lavalley; Carla Maldini; Loïc Guillevin; Alfred Mahr
Journal:  Arthritis Rheum       Date:  2009-10-15

Review 9.  Joint manifestations in Behçet's disease. A review of 340 cases.

Authors:  S Benamour; B Zeroual; F Z Alaoui
Journal:  Rev Rhum Engl Ed       Date:  1998-05

10.  [Thalidomide in the treatment of aphthosis and Behçet's disease. 4 years' experience].

Authors:  H Torras; M Lecha; J M Mascaró/
Journal:  Med Cutan Ibero Lat Am       Date:  1982
View more
  70 in total

Review 1.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  Behcet's disease impairs voice quality without laryngeal and hypopharyngeal involvement.

Authors:  Levent Gurbuzler; Ahmet Inanir; Kursat Yelken; Sema Koc; Ahmet Eyibilen; Ismail Onder Uysal; Ibrahim Aladag
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-05       Impact factor: 2.503

3.  Gender influence on ocular manifestations and their outcome in Behcet's Disease. A long-term follow-up of up to 20 years.

Authors:  Fereydoun Davatchi; Farhad Shahram; Hormoz Shams; Abdolhadi Nadji; Cheyda Chams-Davatchi; Massoomeh Akhlaghi; Seyedeh Tahereh Faezi; Farima Ashofteh; Bahar Sadeghi-Abdollahi
Journal:  Clin Rheumatol       Date:  2010-09-22       Impact factor: 2.980

4.  Ocular manifestations of Behçet's disease in Jordanian patients.

Authors:  Mohammed A Abu-Ameerh; Sawsan F Mohammed; Mona T Mohammad; Osama H Ababneh; Muawyah D Al-Bdour
Journal:  Saudi J Ophthalmol       Date:  2013-07-01

5.  Geographical variations in ocular and extra-ocular manifestations in Behçet's disease.

Authors:  Farhad Shahram; Marthe T Mæhlen; Massoomeh Akhlaghi; Fereydoun Davatchi; Yaping Joyce Liao; Cornelia M Weyand
Journal:  Eur J Rheumatol       Date:  2019-07-19

6.  Fibromyalgia in Behçet's disease: a narrative review.

Authors:  Claire Jobanputra; Roberta H Richey; Jagdish Nair; Robert J Moots; Andreas Goebel
Journal:  Br J Pain       Date:  2017-03-22

Review 7.  Improvement of neurological and ocular symptoms of Behçet's disease after the introduction of infliximab.

Authors:  Marko Barešić; Mirna Reihl; Mario Habek; Nenad Vukojević; Branimir Anić
Journal:  Rheumatol Int       Date:  2018-05-17       Impact factor: 2.631

Review 8.  Diagnostic/classification criteria in pediatric Behçet's disease.

Authors:  Ezgi Deniz Batu
Journal:  Rheumatol Int       Date:  2018-11-14       Impact factor: 2.631

9.  Serum vitronectin levels in patients with Behçet's disease.

Authors:  Ali Yalçındağ; Aslıhan Uzun; F Nilüfer Yalçındağ; Namık Delibaş
Journal:  Inflamm Res       Date:  2012-07-19       Impact factor: 4.575

Review 10.  Similarities and differences between Behçet's disease and Crohn's disease.

Authors:  Veli Yazısız
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.